EPITOME-4, a phase 3b study evaluating a new formulation of epoprostenol sodium in pulmonary arterial hypertension following switch from Flolan®
Yuichi Tamura, Tomohiko Ono, Keiichi Fukuda, Toru Satoh, Shigetake Sasayama
European Respiratory Journal 2013 42: P4084; DOI:
Yuichi Tamura
1Department of Cardiology, Keio University School of Medicine, Tokyo, Japan
Tomohiko Ono
1Department of Cardiology, Keio University School of Medicine, Tokyo, Japan
Keiichi Fukuda
1Department of Cardiology, Keio University School of Medicine, Tokyo, Japan
Toru Satoh
2Department of Cardiology, Kyorin University School of Medicine, Tokyo, Japan
Shigetake Sasayama
3Department of Life and Medical Science, Doshisha University, Kyoto, Japan
Vol 42 Issue Suppl 57
Table of Contents
EPITOME-4, a phase 3b study evaluating a new formulation of epoprostenol sodium in pulmonary arterial hypertension following switch from Flolan®
Yuichi Tamura, Tomohiko Ono, Keiichi Fukuda, Toru Satoh, Shigetake Sasayama
European Respiratory Journal Sep 2013, 42 (Suppl 57) P4084;